Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical OncologyEric P. Winer, Richard L. Schilsky, Maurie Markman et al.|Journal of Clinical Oncology|2008Cited by 290
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research StatementRandall A. Oyer, Lori J. Pierce, Patricia A. Hurley et al.|Journal of Clinical Oncology|2022Cited by 238
Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposureJean‐Jacques Body, Karim Fizazi, Allan Lipton et al.|Journal of Bone and Mineral Research|2009Cited by 120
Abstract GS3-00: First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +/- chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25: SWOG S1007 (RxPonder)Kevin Kalinsky, Lajos Pusztai, William E. Barlow et al.|Cancer Research|2021Cited by 88
Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysisEileen Morgan, Melina Arnold, Colette O’Neill et al.|Breast Cancer Research|2024Cited by 19